A61P 43 - Drugs for specific purposes, not provided for in groups

Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
12/2009
12/16/2009	CN101601708A Preparation method of decoction for dispelling wind
12/16/2009	CN101601702A 抗老化剂 Anti-aging agents
12/16/2009	CN101601692A Double-face external patch for treating night sweat
12/16/2009	CN101601675A Pregnane steroids for use in the treatment of CNS disorders
12/16/2009	CN101601674A Pregnane steroids for use in the treatment of cns disorders
12/16/2009	CN101601665A Use of 1r, 2s-methoxamine in preparing medicament for treating faecal incontinence and other conditions
12/16/2009	CN100569753C A crystalline of 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide methanesulfonate a process for preparing the same
12/16/2009	CN100569228C Fatty acid analogues for treatment of cancer
12/16/2009	CN100569222C Pearl kuding tea lozenge
12/15/2009	US7632933 Corticotropin releasing factor 2 receptor agonists
12/15/2009	US7632930 Oligosaccharide derivative
12/15/2009	US7632871 Methods of making and methods of using antiseptic disinfectant, cosmetic and toiletries, medicine or food containing the same
12/15/2009	US7632870 Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives, preparation and uses thereof
12/15/2009	US7632865 N-(4-(3-chloro-5-trifluoromethyl-2-pyridyloxy)phenyl)-2-chloro-5-nitrothiobenzamide, for example; useful as preventive or therapeutic medicines for diseases accompanied by hyperactivated immune functions
12/15/2009	US7632844 2-hydroxy-6-phenylphenanthridines as PDE-4 inhibitors
12/15/2009	US7632826 Use of agonists of the glucocorticosteroid and/or mineralo-corticosteroid receptors, in particular corticosteroids for the treatment of addiction
12/15/2009	US7632815 Treating or preventing myocardial contractile dysfunction that occurs after a myocardial infarction or other structural heart disease (e.g., end-stage valve disease) by by administering CaMK11 inhibitor, a peptide having a specific sequence of amino acids; dilated cardiomyopathy; transgenic animals
12/15/2009	US7632813 Administering N-(3-{2-[3,4-dimethyl-1,3-thiazolidin-2-ylidene]hydrazino}-2,3-dioxo-1-tetrahydro-2H-pyran-4-ylpropyl)cycloheptanecarboxamideas an inhibitor and a type of parathyroid hormone to treat and/orprevent bone metabolic diseases
12/15/2009	US7632514 a universal polypeptidic carrier for targeting molecules to a Gb3 receptor for the B-subunit of Shiga-Toxin expressing cells and its use for intracellular transport and processing of proteins, peptides, oligopeptides, glycoproteins, etc
12/15/2009	US7632512 Use of polynucleotides encoding small acid-soluble spore protein for inhibiting bacterial cell growth and/or treating bacterial infections
12/15/2009	US7632496 Administering to patient therapeutic dose of cytokine in combination with antibodies directed against tumor associated antigen carbonic anhydrase IX (CAIX/G250/MN); method characterized in significantly reduced cytokine-related toxicity combined with potentiated effectiveness of anti-G250 antibody alone
12/15/2009	CA2501820C Chitosan-containing polysaccharide, method for preparing the same and use thereof
12/15/2009	CA2458837C Composition containing fine particles for carrying biologically active substance thereon or having the same carried thereon and method for preparing them
12/15/2009	CA2422698C Indoline derivatives and their use as 5-ht2 receptor ligands
12/15/2009	CA2403110C N-deacetylthiocolchicine derivatives and pharmaceutical compositions containing them
12/15/2009	CA2398908C Adenosine a2a receptor antagonists for treating and preventing hepatic fibrosis, cirrhosis and fatty liver
12/15/2009	CA2388915C Process for the preparation of n-(4,5-bismethanesulfonyl-2-methyl-benzoyl)guanidine, hydrochloride
12/15/2009	CA2386379C Carbonyl stress-decreasing agent
12/15/2009	CA2374580C Oligomers and polymers of cyclic imino carboxylic acids
12/15/2009	CA2348445C Compositions for the treatment and prevention of cardiovascular diseases
12/15/2009	CA2347905C P53 antisense agent and method
12/15/2009	CA2345138C Polymer conjugates of interferon beta-1a and their uses
12/15/2009	CA2336773C Component b as angiogenic agent in combination with human growth factors
12/15/2009	CA2335617C Use of 3'-azido-2',3'-dideoxyuridine in combination with further anti-hiv drugs for the manufacture of a medicament for the treatment of hiv
12/15/2009	CA2334189C Bridged indenopyrrolocarbazoles
12/15/2009	CA2333125C Alpha emitting constructs and uses thereof
12/15/2009	CA2294996C Angiotensin derivatives
12/15/2009	CA2209315C Gibberellins compounds for veterinary and medicinal applications
12/15/2009	CA2186763C Use of substituted dextranes for treating nervous system damage, and heparane sulphate-enriched fractions
12/10/2009	WO2009148315A1 Method for preventing corticosteroid usage
12/10/2009	WO2009148148A1 Neuroinvasion inhibitor
12/10/2009	WO2009148059A1 Cream-like o/w type emulsified composition and method for producing same
12/10/2009	WO2009148004A1 Novel compound and pharmaceutical application of same
12/10/2009	WO2009147990A1 Novel isoxazole derivative
12/10/2009	WO2009147843A1 Novel uracil compound having inhibitory activity on human deoxyuridine triphosphatase or salt thereof
12/10/2009	WO2009147831A1 Method and pharmaceutical composition for treatment of mental disorders
12/10/2009	WO2009147742A1 Sirna of human osteopontin
12/10/2009	WO2009147218A1 Pharmaceutical combination
12/10/2009	WO2009146594A1 The use of an extract of cistanche tubulosa for preparation of a medicament
12/10/2009	WO2009126950A3 Diterpene glycosides as natural solubilizers
12/10/2009	WO2009123575A8 A photosensitising composition and its uses
12/10/2009	WO2009108760A3 Dendritic macroporous hydrogels prepared by crystal templating
12/10/2009	WO2007096782A3 Compositions for disorders associated wtth metachromatic cell activation
12/10/2009	US20090306408 2-Amino-Bicyclo (3.1.0) Hexane-2,6-Dicarboxylic Ester Derivative
12/10/2009	US20090306213 Process for Synthesis of Glycomimicking Cationic Amphiphiles
12/10/2009	US20090306205 Methoxypolyethylene glycol thioester chelate and uses thereof
12/10/2009	US20090306188 Importation of mitochondrial protein by an enhanced allotopic approach
12/10/2009	US20090306178 Conjugated double strand compositions for use in gene modulation
12/10/2009	US20090306165 Dipeptide compounds containing d-histidine
12/10/2009	US20090306141 Novel Compounds
12/10/2009	US20090306113 Pharmaceutical formulation
12/10/2009	US20090306069 Azolidinone-vinyl fused-benzene derivatives
12/10/2009	US20090305991 33 Human Secreted Proteins
12/10/2009	US20090305980 Methods and Compositions Related to TR4
12/10/2009	US20090305978 Methods for increasing the size of animals using needleless delivery constructs
12/10/2009	US20090305976 Cytokine Mediating Composition
12/10/2009	US20090305952 Anionic polyamide functionalized with a tryptophan unit
12/10/2009	US20090304796 Nanoparticle suitable for delivery of a biomolecule into or out of a membrane enclosed cell or cell organelle
12/10/2009	US20090304709 Modulators of p-selectin glycoprotein ligand 1
12/10/2009	US20090304708 Preparation for the Prevention and/or Treatment of a Tissue Change of Mesenchymal Origin
12/10/2009	US20090304669 Preparative purification process for human furin
12/10/2009	US20090304645 In vitro engineered, regenerated urinary tract tissue compositions and methods for producing same
12/10/2009	US20090304644 Systems and methods for manipulation of regenerative cells separated and concentrated from adipose tissue
12/10/2009	US20090304642 Methods of specifying mesodermal, endodermal and mesoendodermal cell fates
12/10/2009	US20090304639 Method for preparing an organ for transplantation
12/10/2009	US20090304599 Protein Nanoparticles and the Use of the Same
12/10/2009	US20090304593 Detection of the detachment of immobilized contrast agent in medical imaging applications
12/10/2009	US20090304589 Radiation sensitive liposomes
12/10/2009	CA2726890A1 Creamy o/w emulsion composition and production process thereof
12/10/2009	CA2726885A1 Sirna of human osteopontin
12/10/2009	CA2726644A1 Pharmaceutical combination
12/10/2009	CA2726579A1 Novel uracil compound or salt thereof having human deoxyuridine triphosphatase inhibitory activity
12/10/2009	CA2725316A1 Novel isoxazole derivative
12/09/2009	EP2130920A2 Beta-like glycoprotein hormone polypeptide and heterodimer
12/09/2009	EP2130829A1 Novel hydroxyindole derivative
12/09/2009	EP2130828A1 Sulfonamide derivative
12/09/2009	EP2130552A1 Pharmaceutical composition comprising anti-grp78 antibody as active ingredient
12/09/2009	EP2130548A2 Growth Hormone Releasing Peptides
12/09/2009	EP2130537A1 N3 alkylated benzimidazole derivatives as mek inhibitors
12/09/2009	EP2130536A1 N3 alkylated benzimidazole derivatives as mek inhibitors
12/09/2009	EP2129379A1 Imidazoquinolines as dual lipid kinase and mtor inhibitors
12/09/2009	EP1679370B1 Method of evaluating cancerization degree
12/09/2009	EP1554256B1 Piperidino pyrimidine dipeptidyl peptidase inhibitors for the treatment of diabetes
12/09/2009	EP1519939B1 N-aryl diazaspiracyclic compounds and methods of preparation and use thereof
12/09/2009	EP1458754B1 Novel death associated proteins of the thap family and related par4 pathways involved in apoptosis control
12/09/2009	EP1409450B1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds
12/09/2009	EP1392642B1 Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
12/09/2009	EP1252144B1 Substituted glutarimides and use thereof il-12 production inhibitors
12/09/2009	EP1129110B1 Platelet-derived growth factor d, dna coding therefor, and uses thereof
12/09/2009	EP1119614B1 Protein tyrosine phosphatase-1b (ptp-1b) deficient mice and uses thereof

1 ... 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 ... 1564